News | July 31, 2024
Fredun Pharmaceuticals Q1 FY25 PAT drops QoQ to Rs. 4.12 Cr
Fredun Pharmaceuticals has reported total income of Rs. 78.81 crores during the period ended June 30, 2024
Fredun Pharmaceuticals has reported total income of Rs. 78.81 crores during the period ended June 30, 2024
Indoco Remedies is addressing the observations comprehensively and will respond to the USFDA within the stipulated timeframe
The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants
Shilpa Biologicals has developed high concentration adalimumab (100 mg/mL)
Torrent Pharmaceuticals has reported total income of Rs. 2,883 crores during the period ended June 30, 2024
The drug will be manufactured at the group's formulation manufacturing facility in Ahmedabad SEZ - II, India
Contepo offers a unique mechanism of action and has the potential to address increasing antibiotic resistance and gaps in the current antibiotic treatment landscape
Kwality Pharma already has registration of 20 molecules from the units and 20 are under registration
The company will address these observations within the stipulated timeline
Sacubitril and Valsartan combination is used to treat chronic heart failure in adults
Subscribe To Our Newsletter & Stay Updated
